The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 2, 1998, Pages 231-234

  Hadley, Andrew G ^a   Wilkes, Anthony ^a   Goodrick, Jean ^b   Penman, David ^c   Soothill, Peter ^c   Lucas, Geoffrey ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b The Bristol Blood Centre   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; RHESUS D ANTIBODY;

ALLOIMMUNIZATION; AMNIOCENTESIS; ARTICLE; AUTOANALYZER; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; HIGH RISK PREGNANCY; HUMAN; NEWBORN HEMOLYTIC DISEASE; PREDICTION; PRIORITY JOURNAL;

AMNIOCENTESIS; CHEMILUMINESCENT MEASUREMENTS; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; INFANT, NEWBORN; PREDICTIVE VALUE OF TESTS; PREGNANCY; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0031907504     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10059.x     Document Type: Article

References (10)

1. Hadley AG. In vitro assays to predict the severity of hemolytic disease of the newborn. Transfus Med Rev 1995; 9: 302–310.
2. Pratt GA, Bowell PJ, MacKenzie IZ et al. Production of atypical alloantibodies in Rh (D)-sensitized pregnancies managed by intrauterine investigation methods. Clin Lab Haematol 1989; 11: 241–248.
3. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunization. Br J Med 1992; 304: 1155–1156.
4. Bowell P, Wainscoat JS, Peto TEA, Gunson HH. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn. BMJ 1982; 285:327–329.
5. Noble AL, Poole GD, Anderson N, Lucas GF, Hadley AG. Predicting the seventy of haemolytic disease of the newborn: an assessment of the clinical usefulness of the chemiluminescence test. Br J Haematol 1995; 90: 718–720.
6. Hadley AG, Garner SF, Taverner JM. AutoAnalyzer quantification, monocyte-mediated cytotoxicity and chemiluminescence assays for predicting the severity of haemolytic disease of the newborn. Trans fus Med 1993; 3: 195–200.
7. Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991; 77: 221–228.
8. Buggins AGS, Thilaganathan B, Hambley H, Nicolaides KH. Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation. Br J Haematol 1994; 88: 199–200.
9. Hadley AG, Poole GD, Fraser ID. Predicting the severity of haemolytic disease of the newborn: prospective evaluation of the chemiluminescence test. Vox Sang 1992; 63: 291–292.
10. Albar H, Harman CR, Pollock J. et al. Amniotic fluid spectrophotometry for evaluation of alloimmune disease in mid-trimester. Br J Obstet Gynaecol 1993; 100: 772.